The pulmonary circulation in bronchopulmonary dysplasia

Seminars in Neonatology

Volumn 8, Issue 1, 2003, Pages 51-62

  Parker, Thomas A ^a,b   Abman, Steven H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Alveolar simplification; Bronchopulmonary dysplasia; Chronic lung disease; Nitric oxide; Prematurity; Pulmonary hypertension

Indexed keywords

ANGIOGENESIS INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; HYDRALAZINE; NIFEDIPINE; NITRIC OXIDE; OXYGEN; PROSTACYCLIN;

AIR SAC; ANGIOGENESIS; ARTIFICIAL VENTILATION; BLOOD VESSEL INJURY; CLINICAL TRIAL; DISEASE MODEL; HIGH RISK PATIENT; HUMAN; HYPEROXIA; INFANT; INFLAMMATION; LUNG ALVEOLUS; LUNG CIRCULATION; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG FIBROSIS; LUNG HEMODYNAMICS; MORBIDITY; MORTALITY; NONHUMAN; OXYGEN THERAPY; OXYGEN TOXICITY; PATHOGENESIS; PREMATURITY; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM;

EID: 0037299066     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-2756(02)00191-4     Document Type: Review

References (67)

1. Northway WH Jr., Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967;276:357-68.
2. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999;46:641-3.
3. Hislop AA, Haworth SG. Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol 1990;9:152-61.
4. Mitchell SH, Teague WG. Reduced gas transfer at rest and during exercise in school age survivors of bronchopulmonary dysplasia. Am J Respir Crit Care Med 1998;157:1406-12.
5. Roberts RJ, Weesner KM, Bucher JR. Oxygen-induced alterations in lung vascular development in the newborn rat. Pediatr Res 1983;17:368-75.
6. Jones R, Zapol WM, Reid L. Pulmonary artery remodeling and pulmonary hypertension after exposure to hyperoxia for 7 days: a morphometric and hemodynamic study. Am J Pathol 1984;117:273-85.
7. Jones R, Zapol WM, Reid L. Oxygen toxicity and restructuring of pulmonary arteries-a morphometric study: the response to 4 weeks' exposure to hyperoxia and return to breathing air. Am J Pathol 1985;121:212-23.
8. Wilson WL, Mullen M, Olley PM, Rabinovitch M. Hyperoxia-induced pulmonary vascular and lung abnormalities in young rats and potential for recovery. Pediatr Res 1985;19:1059-67.
9. Jones R. Ultrastructural analysis of contractile cell development in lung microvessels in hyperoxic pulmonary hypertension. Fibroblasts and intermediate cells selectively reorganize nonmuscutar segments. Am J Pathol 1992;141(6):1491-505.
10. Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 2001;280:C719-41.
11. O'Donovan DJ, Fernandes CJ. Mitochondrial glutathione and oxidative stress: implications for pulmonary oxygen toxicity in premature infants. Mol Genet Metab 2001;71:352-8.
12. Uhlig S. Mechanotransduction in the lung. Ventilation-induced lung injury and mechanotransduction: stretching it too far? Am J Physiol Lung Cell Mol Physiol 2002;282:L892-6.
13. Kulik TJ, Alvarado SP. Effect of stretch on growth and collagen synthesis in cultured rat and lamb pulmonary arterial smooth muscle cells. J Cell Physiol 1993;157:615-24.
14. Kolpakov V, Rekhter MD, Gordon D, Wang WH, Kulik TJ. Effects of mechanical forces on growth and matrix protein synthesis in the in vitro pulmonary artery. Circ Res 1995;77:823-31.
15. Quinn TP, Schlueter M, Soifer SJ, Guitierrez JA. Cyclic mechanical stretch induces VEGF and FGF-2 expression in pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2002;282(5):L897-903.
16. Dreyfuss D, Basset G, Soler P, Saumon G. Intermittent positive-pressure hyperventilation with high inflation pressure produces pulmonary microvascular injury in rats. Am Rev Respir Dis 1985;132:880-4.
17. Bland RD, Albertine KH, Carlton DP, Kullama L, Davis P, Cho S-C et al. Chronic lung injury in preterm lambs: abnormalities of the pulmonary circulation and lung fluid balance. Pediatr Res 2000;48:64-74.
18. Meyrick BO, Ryan US, Brigham KL. Direct effects of E. coli endotoxin on structure and permeability of pulmonary endothelial monolayers and the endothelial layer of intimal explants. Am J Pathol 1986;122:140-51.
19. Meyrick B, Berry LC Jr., Christman BW. Response of cultured human pulmonary artery endothelial cells to endotoxin. Am J Physiol 1995;268:L239-44.
20. Coalson JJ, Gerstmann DR, Winter VT, DeLemos RA. Bacterial colonization and infection studies in the premature baboon with bronchopulmonary dysplasia. Am Rev Respir Dis 1991;144:1140-6.
21. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996;97(2):210-5.
22. Introna M, Mantovani A. Early activation signals in endothetial cells: stimulation by cytokines. Arterioscler Thromb Vasc Biol 1997;17:423-8.
23. Mirro R, Armstead W, Leffler C. Increased airway leukotriene levels in infants with severe bronchopulmonary dysplasia. Am J Dis Child 1990;144:160-1.
24. Niu JO, Munshi UK, Siddiq MM, Parton LA. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia. J Pediatr 1998;132:965-70.
25. Ivy DD, Parker TA, Kinsella JP, Abman SH. Endothelin A receptor blockade decreases pulmonary vascular resistance in premature lambs with hyaline membrane disease. Pediatr Res 1998;44(2):175-80.
26. Ivy DD, Parker TA, Ziegler JW, Galan HL, Kinsella JP, Tuder RM et al. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J Clin Invest 1997;99(6):1179-86.
27. Davie N, Haleen SJ, Upton PD, Polak JM, Yacoub MI, Morrell NW et al. ETA and ETB receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 2002;165:398-405.
28. Zamora MR, Stelzner TJ, Webb S, Panos RJ, Ruff LJ, Dempsey EC. Overexpression of endothelin-1 and enhanced growth of pulmonary artery smooth muscle cells from fawn-hooded rats. Am J Physiol 1996;270:L101-9.
29. Schreiber MD, Heymann MA, Soifer SJ. Leukotriene inhibition prevents and reverses hypoxic pulmonary vasoconstriction in newborn lambs. Pediatr Res 1985;19(5):437-41.
30. Stenmark KR, James SL, Voelkel NF, Toews WH, Reeves JT, Murphy RC. Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. N Engl J Med 1983;309(2):77-80.
31. Halliday H, Hirschfeld S, Riggs T, Liebman J, Fanaroff A, Bormuth C. Respiratory distress syndrome: echocardiographic assessment of cardiovascular function and pulmonary vascular resistance. Pediatrics 1977;60(4):444-9.
32. Evans NJ, Archer LNJ. Doppler assessment of pulmonary artery pressure and extrapulmonary shunting in the acute phase of hyaline membrane disease. Arch Dis Child 1991;66:6-11.
33. Evans NJ, Archer LNJ. Doppler assessment of pulmonary artery pressure during recovery from hyaline membrane disease. Arch Dis Child 1991;66:802-4.
34. Walther FJ, Benders MJ, Leighton JO. Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome. Pediatrics 1992;90:899-904.
35. Gill AB, Weindling AM. Raised pulmonary artery pressure in very low birthweight infants requiring supplemental oxygen at 36 weeks after conception. Arch Dis Child 1995;72:F20-2.
36. Seppanen MP, Kaapa PO, Kero PO, Saraste M. Doppler-derived systolic pulmonary artery pressure in acute neonatal respiratory distress syndrome. Pediatrics 1994;93:769-73.
37. Gill AB, Weindling AM. Pulmonary artery pressure changes in the very low birthweight infant developing chronic lung disease. Arch Dis Child 1993;68:303-7.
38. Subhedar NV, Shaw NJ. Changes in pulmonary arterial pressure in preterm infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 2000;82:F243-7.
39. Abman SH, Wolfe RR, Accurso FJ, Koops BL, Bowman M, Wiggins JW. Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics 1985;75:80-4.
40. Berman W Jr., Yabek SM, Dillon T, Burstein R, Corlew S. Evaluation of infants with bronchopulmonary dysplasia using cardiac catheterization. Pediatrics 1982;70:708-12.
41. Bush A, Busst CM, Knight WB, Hislop AA, Haworth SG, Shinebourne EA. Changes in pulmonary circulation in severe bronchopulmonary dysplasia. Arch Dis Child 1990;65:739-45.
42. Goodman G, Perkin RM, Anas NG, Sperling DR, Hicks DA, Rowen M. Pulmonary hypertension in infants with bronchopulmonary dysplasia. J Pediatr 1988;112:67-72.
43. Fouron J-C, Le Guennec J-C, Villenamt D, Bard H, Perreault G, Davignon A. Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn. Pediatrics 1980;65:529-35.
44. Garg M, Kurzner SI, Bautista D, Keens TG. Clinically unsuspected hypoxia during sleep and feeding in infants with bronchopulmonary dysplasia. Pediatrics 1988;81(5):635-42.
45. Calder NA, Williams BA, Smyth J, Boon AW, Kumar P, Hanson MA. Absence of ventilatory responses to alternating breaths of mild hypoxia and air in infants who have had bronchopulmonary dysplasia: implications for the risk of sudden infant death syndrome. Pediatr Res 1994;35(6):677-81.
46. Garg M, Kurzner SI, Bautista D, Keens TG. Hypoxic arousal responses in infants with bronchopulmonary dysplasia. Pediatrics 1988;82(1):59-63.
47. Sekar KC, Duke JC. Sleep apnea and hypoxemia in recently weaned premature infants with and without bronchopulmonary dysplasia. Pediatr Pulmonol 1991;10(2):112-6.
48. Abman SH, Accurso FJ, Brown CM. Unsuspected cardiopulmonary abnormalities complicating bronchopulmonary dysplasia. Arch Dis Child 1984;59:966-70.
49. Saugstad OD. Chronic lung disease: oxygen dogma revisited. Acta Pediatr 2001;90:113-5.
50. Abman SH, Accurso FJ, Koops BL. Experience with home oxygen in the management of infants with bronchopulmonary dysplasia. Clin Pediatr 1985;23(9):471-6.
51. Stenmark KR, Fasules J, Hyde DM, Voelkel NF, Henson J, Tucker A et al. Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 meters. J Appi Physiol 1987;62(2):821-30.
52. Wohrley JD, Frid MG, Moiseeva EP, Orton EC, Belknap JK, Stenmark KR. Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. J Clin Invest 1995;96(1):273-81.
53. STOP·ROP Multicenter Study Group. Supplemental oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. 1. Primary outcomes. Pediatrics 2000;105:295-310.
54. Massaro GD, Olivier J, Massaro D. Short-term perinatal 10% 02 alters postnatal development of lung alveoli. Am J Physiol 1989;257:L221-5.
55. Simoneau G, Escourrou P, Doroux P, Lockhart A. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med 1981;304:1582-5.
56. Brownlee JR, Beekman RH, Rosenthal A. Acute hemodynamic effects of nifedipine in infants with broncho-pulmonary dysplasia and pulmonary hypertension. Pediatr Res 1988;24:186-90.
57. Johnson CE, Beekman RH, Kostyshak DA, Nguyen T, Oh D, Amidon G. Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension. Pediatr Res 1991;29:500-3.
58. Banks BA, Seri I, Ischiropoulos H, Merrill J, Rychik J, Ballard RA. Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics 1999;103:610-8.
59. Ivy DD, Griebel JL, Kinsella JP, Abman SH. Acute hemodynamic effects of pulsed delivery of low flow nasal nitric oxide in children with pulmonary hypertension. J Pediatr 1998;133(3):453-6.
60. Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, Abman SH. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 1997;41:457-63.
61. Albertine KH, Sun J, Dahl MJ, Sweeley J, Carlton DP, Bland RD. Lung abundance of vascular endothetiat growth factor and its receptor, fetal liver kinase-1, proteins coincides with perinatat changes of pulmonary capillary surface density in sheep. Pediatr Res 2002;51(4):63A.
62. Jakkuta M, LeCras TD, Gebb S, Hirth KP, Tuder RM, Voetket NF et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000;279:L600-7.
63. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, Huyck H. Angiogenic factors and alveolar vascutature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 2002;282:L811-23.
64. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Mettay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;164:1971-80.
65. Abman SH. Bronchopulmonary dysplasia: 'a vascular hypothesis'. Am J Respir Crit Care Med 2002;164:1755-6.
66. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, LeCras TD, Abman S, Hirth PK et al. Inhibiton of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000;106:1311-9.
67. Grover TR, Zenge JP, LeCras TD, Kinsella JP, Markham NE, Abman SH. Inhibition of vascular endothelial growth factor impairs pulmonary vascular growth and decreases endothelial nitric oxide synthase expression in the late gestation ovine fetus. Pediatr Res 2001;49(4):304A.